PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 79 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 44.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,067,000 | -24.1% | 543,870 | +1.6% | 0.00% | 0.0% |
| Q4 2019 | $2,725,000 | +4.2% | 535,181 | +3.5% | 0.00% | -50.0% |
| Q3 2019 | $2,615,000 | -12.5% | 517,172 | +6.8% | 0.00% | 0.0% |
| Q2 2019 | $2,989,000 | +33.2% | 484,428 | +0.2% | 0.00% | +100.0% |
| Q1 2019 | $2,244,000 | +18.7% | 483,468 | +7.4% | 0.00% | 0.0% |
| Q4 2018 | $1,890,000 | -33.9% | 449,990 | -1.3% | 0.00% | -50.0% |
| Q3 2018 | $2,858,000 | -9.2% | 455,738 | +16.5% | 0.00% | 0.0% |
| Q2 2018 | $3,147,000 | +16.6% | 391,345 | +8.2% | 0.00% | 0.0% |
| Q1 2018 | $2,698,000 | +39.4% | 361,621 | +11.1% | 0.00% | 0.0% |
| Q4 2017 | $1,936,000 | -18.4% | 325,356 | +0.9% | 0.00% | 0.0% |
| Q3 2017 | $2,374,000 | +13.9% | 322,424 | +5.1% | 0.00% | 0.0% |
| Q2 2017 | $2,084,000 | -35.5% | 306,843 | -10.3% | 0.00% | -33.3% |
| Q1 2017 | $3,231,000 | +36.0% | 342,204 | +24.5% | 0.00% | 0.0% |
| Q4 2016 | $2,376,000 | +26.7% | 274,933 | -7.2% | 0.00% | +50.0% |
| Q3 2016 | $1,876,000 | +104.6% | 296,227 | +36.4% | 0.00% | +100.0% |
| Q2 2016 | $917,000 | +104.7% | 217,100 | +111.6% | 0.00% | 0.0% |
| Q1 2016 | $448,000 | -28.8% | 102,600 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $629,000 | +3.6% | 102,600 | -3.2% | 0.00% | 0.0% |
| Q3 2015 | $607,000 | -70.9% | 106,000 | -62.1% | 0.00% | -66.7% |
| Q2 2015 | $2,087,000 | +24.7% | 279,664 | 0.0% | 0.00% | +50.0% |
| Q1 2015 | $1,673,000 | +108.6% | 279,664 | +163.8% | 0.00% | +100.0% |
| Q4 2014 | $802,000 | +45.6% | 106,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $551,000 | +20.6% | 106,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $457,000 | +5.3% | 106,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $434,000 | -4.2% | 106,000 | +24.9% | 0.00% | 0.0% |
| Q4 2013 | $453,000 | +11.9% | 84,900 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $405,000 | +33.7% | 84,900 | +30.0% | 0.00% | 0.0% |
| Q2 2013 | $303,000 | – | 65,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|